
Cardiometabolic Medicine
The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. In no therapeutic area is this more essential than in “Cardiometabolic Medicine,” a new term meant to encompass the interconnected and debilitating diagnoses of diabetes mellitus, heart failure, coronary artery disease/acute coronary syndrome, progressive renal insufficiency, and related disorders such as hypertension, hyperlipidemia, and hyperkalemia. These areas are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.
Managing Anti-FXa-DOAC-Associated Hemorrhage and The Role of Laboratory Testing
1b) Our expert author is #pharmacist Craig Beavers, PharmD @beaverspharmd CV Clinical Pharmacy Specialist @UK_COP, and Immediate Past Chair of the...
AHA2022 UPDATE: RENOPROTECTIVE EFFECTS OF SGLT2-I AND COLLABORATIVE META-ANALYSIS OF LARGE PLACEBO-CONTROLLED TRIALS
2a) The same weekend that Will Herrington @willkidney, @The_MRC @Kidney_Research UK @Oxford_NDPH presented #EMPA_KIDNEY results at #ASN22 (see...
New Data on SGLT2i and Progression of Renal Disease from ASN2022
2) This work was presented by Will Herrington @willkidney, @The_MRC @Kidney_Research UK funded AssocProf @Oxford_NDPH and representing the...
Summary of Available Data on Specific DOAC Reversal and Nonspecific Factor Repletion in Patients with aFXa-DOAC-Associated Hemorrhage
2) This 🆓program is accredited for 0.5h CE/#CME for #physicians #physicianassociates #nurses #nurespractitioners #pharmacists and is supported by a...
The New Standard in Mineralocorticoid Receptor Antagonism: Why Being Nonsteroidal Matters
2) This series is supported by educational grants from AstraZeneca & Bayer, & is intended for healthcare professionals. Accreditation...
CASE CHALLENGE: ICH IN A DOAC-ANTICOAGULATED PATIENT
1b) #Physicians #Nurses #Pharmacists #physicianassociate #NPs earn 0.5h CE/#CME from @academiccme for following this 🧵...
Update on New HFrEF Data from ESC 2022 with a Focus on Vericiguat
2) @GiuseppeGalati_ is at San Raffaele Research Hospital, Milan 🇮🇹 @SanRaffaeleMI. This program is intended for #healthcare professionals & is...
Strategies to Minimize Glucose Variability with the Application of Newer Longer-acting Insulins
2) This program is supported by an educational grant from Sanofi and is intended for healthcare professionals. Statement of accreditation and...
Management of Older Adults with Type 2 Diabetes & Frailty
2) Statement of accreditation and faculty disclosures can be viewed at https://t.co/gvXca4XKOU. @cardiomet_CE is your ONLY source for #accredited...
Familial Hypercholesterolemia and Primary Care
2a) This is the next instalment of @cardiomet_CE‘s 10-part foundational series on #lipid_management! It is accredited for #CME/CE and intended for...
@Cardiomet_CE on Twitter
Your only source for ACCREDITED SoMe-delivered
serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!
On Twitter at @cardiomet_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr – 1.0hr CE/CME. Programs are presented by expert faculty in engaging and fully interactive format. Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.